Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX) announced results from the IMPROVE study in laparoscopic colectomy. IMPROVE represents a series of open-label ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE